Safety and Efficacy of Caproamin Fides and Tranexamic Acid Versus Placebo in Patients Undergoing Coronary Artery Revascularization | Zendy

Alireza Alizadeh Ghavidel | Zendy; Ziae Totonchi | Zendy; Mitra Chitsazan | Zendy; Maziar Gholampour Dehaki | Zendy; Farshid Jalili | Zendy; Bahram Fariborz Farsad | Zendy; Maral Hejrati | Zendy

Open Access

Safety and Efficacy of Caproamin Fides and Tranexamic Acid Versus Placebo in Patients Undergoing Coronary Artery Revascularization

Author(s) -

Alireza Alizadeh Ghavidel,

Ziae Totonchi,

Mitra Chitsazan,

Maziar Gholampour Dehaki,

Farshid Jalili,

Bahram Fariborz Farsad,

Maral Hejrati

Publication year - 2014

Publication title -

journal of cardiovascular and thoracic research

Language(s) - English

Resource type - Journals

eISSN - 2008-6830

pISSN - 2008-5117

DOI - 10.15171/jcvtr.2014.011

Subject(s) - medicine , fides , tranexamic acid , placebo , anesthesia , perioperative , surgery , blood loss , alternative medicine , theology , faith , pathology , philosophy

Excessive fibrinolysis contributes to post-cardiopulmonary bypass bleeding. Tranexamic Acid (TXA) and Caproamin Fides are synthetic lysine analogues that inhibit plasminogen-fibrin binding. The present study aimed to compare TXA and Caproamin Fides versus placebo in patients undergoing elective coronary artery revascularization.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Our institutional solutions Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Discover

Explore

Home ZAIA Blog